Banksia Scientific

20/08/2025

20/08/2025

Dear our valued customers, colleagues and friends,

Banksia Scientific is excited to be exhibiting the Randox range of solutions at next week's NZIMLS Annual Scientific Meeting in Hamilton! Randox is one of the world's leading manufacturers of laboratory Quality Control and premium Reagents. With over 40 years of manufacturing and distribution experience, across 145 countries, Randox offer premium solutions for common and niche chemistry, immunology, haematology and molecular assays.

Come by our booth next week to chat all things Quality Control and superior methodology Reagents! If you would like to book a specific meeting time with a dedicated Randox representative, please reply to this email to arrange.

We look forward to seeing you in Hamilton!

NZIMLS Annual Scientific Meeting - 27 - 29 August 2025, Hamilton

03/04/2025

New Zealand Pathology Labs, have you looked at consolidating your controls? Contact Banksia to see how Randox controls can help help you!

How can Randox Quality Control help your laboratory consolidate? Watch our QC Consolidation video to find out more.

05/03/2025

A notice to all our valued Customers & Clients.

Our New Zealand branch remains operating as normal.

17/10/2024

Banksia Scientific is excited to announce that we are now the official distributor of Randox products in New Zealand. We are committed to providing top-notch support and supplying the comprehensive Randox range to our customers.

Access the Randox range of products at https://www.randox.com/

For further information, feel free to reach out to us at sales@banksiascientific.co.nz.

22/08/2024

https://banksiascientific.com.au/mycoplasma-contamination-detection-removal/

Mycoplasma Contamination - MP Biomedicals launch new kit for rapid detection of mycoplasma: Myco-Visible Mycoplasma LAMP Detection Kit.

14/06/2024

https://banksiascientific.com.au/gut-microbiome-and-colitis-research-webinar/

Overcome Sample Preparation Challenges in Gut Microbiome and Colitis Research by attending this webinar! Join MP's webinar...

08/05/2024

https://banksiascientific.com.au/ansh-labs-gastric-inhibitory-polypeptide-gip-elisa-total-and-intact-assays-available/

Ansh Labs - Gastric Inhibitory Polypeptide (GIP) ELISA Total and Intact Assays Available

08/05/2024

https://banksiascientific.com.au/spineasy-dna-and-rna-kit-for-yeast/

SPINeasy® DNA Kit for Yeast is a high-performance genomic DNA (gDNA) extraction kit which is developed based on silica-membrane spin-column technology.

28/04/2024

https://banksiascientific.com.au/ansh-labs-key-study-activin-a-and-follistatin-like-3/

Activin A and Follistatin-Like 3 - Cardiovascular diseases are a leading cause of maternal death worldwide. Peripartum cardiomyopathy (PPCM), an idiopathic form of acute systolic heart failure (HF) that occurs during late pregnancy or early postpartum, is a major cause of maternal mortality.

22/04/2024

FASTest BEE 3T

04/04/2024

is - BioChain Institute, Inc. honors those fighting the disease, survivors and the ones taken. - https://bit.ly/38v8VHe

The study below shows that New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs Brain tissue control samples were obtained from BioChain Institute, Inc.

account for 85% to 90% of all primary central nervous system (CNS) tumors. Worldwide, an estimated
308,102 people were diagnosed with a primary brain or spinal cord tumor in 2020. About 4,170 children under the age of 15 will also be diagnosed with a brain or CNS tumor this year in the United States